Methods

Western blotting analysis (Figure S1)
Jurkat, THP-1, KG-1 or NK92 cells (6.0×10 5 cells) were seeded on 12 well plates and each carrier was added to the cells at siRNA doses of 1-30 nM. The RNAiMAX was prepared following the manufacturer's instructions. The RNAiMAX reagent (0.3 µl) was mixed with 1 nmol of siRNA. The cells were then incubated for 2 h at 37°C in 0.5 ml of serum-free OPTI-MEM I. After a 2 h incubation period, 0.5 ml of culture medium was added to the cells, followed by a further incubation for 46 h. After the incubation, the cells were collected and washed with PBS. The cells were lysed with 50 µl of RIPA buffer (50 mM Tris-HCl (pH7.4), 1% NP-40, 0.5% Na-deoxyxholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA) containing 1 µl of protease inhibitor cocktail (Nacalai tesque, Kyoto, Japan) for 30 min on ice. The lysates were then centrifuged and the supernatants were obtained as cell lysates. The cell lysates were heated (95°C, 5 min) with an equal volume of loading buffer (100 mM Tris-HCl (pH 6.8), 4% SDS, 12% 2-mercaptoethanol, 20% glycerol, 0.05% bromophenol blue), and then subjected to 10% SDS-PAGE. After electrophoresis, the proteins were electroblotted onto a Polyvinylidene Fluoride membrane (GVS, Bologna, Italy) and the membranes were then blocked with 2% skim milk. After blocking, a primary antibody from mouse against GAPDH1 (Abcam, Cambridge, UK) and from rabbit against alpha-tubulin (Cell Signaling Technology, Danvers, MA) were used at dilutions of 1:1250 and 1:1000, respectively. Secondary HRP-conjugated anti-mouse (GE Healthcare UK Ltd, Buckinghamshire, England) or anti-rabbit antibodies (Thermo Fisher Scientific, Waltham, MA) were then used at dilutions of 1:1000 and 1:4000, respectively. Blots were developed with Amersham ECL Plus Western Blotting Detection System (GE Healthcare).
Immunoreactive bands were visualized using LAS 4000 (Fujifilm, Tokyo, Japan).
Evaluation of cellular uptake (Figure S2)
Jurkat, THP-1, KG-1 or NK92 cells (6.0×10 5 cells) were incubated with Cy5-siRNA loaded YSK12-MEND or RNAiMAX at siRNA concentrations of 0.3-30 nM for 2 h at 37°C in 0.5 mL of serum-free OPTI-MEM I in 12 well plate. When we prepared Cy5-siRNA loaded YSK12-MEND or RNAiMAX, a GAPDH siRNA solution containing 10% Cy5-siRNA was
